Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerReverse phase protein microarrays advance to use in clinical trialsThe COXEN principle: translating signatures of in vitro chemosensitivity into tools for clinical outcome prediction and drug discovery in cancer.Proteomics, morphoproteomics, saliva and breast cancer: an emerging approach to guide the delivery of individualised thermal therapy, thermochemotherapy and monitor therapy response.Biomarkers for bladder cancer management: present and future.A pilot characterization of human lung NSCLC by protein pathway activation mapping.Urothelial carcinomas: a focus on human epidermal receptors signalingFunctional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.Differential Expression Profile of Chicken Embryo Fibroblast DF-1 Cells Infected with Cell-Adapted Infectious Bursal Disease Virus.The interconnectedness of cancer cell signaling.Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer.Evidence for PTEN-independent Akt activation and Akt-independent p27(Kip1) expression in advanced bladder cancer.Microarray-integrated optoelectrofluidic immunoassay systemThe War on Cancer rages on.Array-based pharmacogenomics of molecular-targeted therapies in oncology.Array-based proteomic approaches to study signal transduction pathways: prospects, merits and challenges.Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors.Expression and function role of DNA methyltransferase 1 in human bladder cancer.
P2860
Q24628746-57C2AFF3-D597-4A8D-8319-F293C5AF6F31Q28384553-F3DB3725-57CF-4ECC-BCE0-04AED5EA980FQ30433023-E00AD57A-28CB-4C68-BE74-0E87DAE4DDC7Q33694698-49338FDA-E8CF-4A25-BBF2-D276B443F88CQ34448168-2676FA4F-5CF8-4319-B7BD-39EA684F1126Q34478770-FA70C777-8067-4541-BD38-5EFC33A0C3BCQ35172558-D84BBF13-953B-4EB5-8C4F-078B04A8E3FFQ35328194-FB5B8D25-A3B7-4298-93E5-147C3084E967Q35656851-F6758BD4-1FF0-4B19-8473-E709CD0B5BB2Q35669733-2D3D55A0-32AF-4B7A-8A9D-74FAA50D90EAQ35767570-BF3882ED-5022-4A6E-8616-6F297BE35E10Q36121689-B4D6EC19-B966-4EE0-85E6-9B774B98DABDQ36901049-1276A884-39B1-4677-AC78-E805A188070EQ37478602-D542A7D1-FE69-47E3-969C-07C501C2A946Q37976288-74AD0A1F-B70C-4464-B47C-1A72F19BF640Q38255299-2B936613-162D-42D4-B17E-681A52F2CDF0Q52297317-1AFB31EE-85D8-4AE0-BCDE-B3D785C1695BQ54594046-C0ADD10F-278F-4B5B-9144-0B8FDBE5251E
P2860
Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparison of global versus ep ...... sensitivity in bladder cancer.
@ast
Comparison of global versus ep ...... sensitivity in bladder cancer.
@en
type
label
Comparison of global versus ep ...... sensitivity in bladder cancer.
@ast
Comparison of global versus ep ...... sensitivity in bladder cancer.
@en
prefLabel
Comparison of global versus ep ...... sensitivity in bladder cancer.
@ast
Comparison of global versus ep ...... sensitivity in bladder cancer.
@en
P2093
P2860
P356
P1433
P1476
Comparison of global versus ep ...... sensitivity in bladder cancer.
@en
P2093
Charles R Owens
Dan Theodorescu
Dmytro M Havaleshko
Emanuel F Petricoin
HyungJun Cho
Julia D Wulfkuhle
Lance A Liotta
Sooyoung Cheon
Steven Christopher Smith
P2860
P304
P356
10.1593/NEO.09898
P577
2009-11-01T00:00:00Z